Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
7.61
+0.32 (4.39%)
At close: Mar 9, 2026, 4:00 PM EDT
7.16
-0.45 (-5.91%)
After-hours: Mar 9, 2026, 4:57 PM EDT
Adicet Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 77 | 87 | 82 | 383 | 685 | 275 | |
| Market Cap Growth | -15.34% | 7.13% | -78.70% | -44.04% | 148.60% | - | |
| Enterprise Value | -15 | -96 | -80 | 122 | 513 | 167 | |
| Last Close Price | 7.29 | 15.39 | 30.24 | 143.04 | 279.84 | 224.80 | |
| PS Ratio | - | - | - | 15.33 | 70.36 | 15.38 | |
| PB Ratio | 0.38 | 0.47 | 0.48 | 1.31 | 2.26 | 2.51 | |
| P/TBV Ratio | 0.67 | 0.47 | 0.48 | 1.40 | 2.41 | 3.11 | |
| EV/Sales Ratio | - | - | - | 4.89 | 52.72 | 9.34 | |
| Debt / Equity Ratio | 0.14 | 0.09 | 0.12 | 0.07 | 0.07 | 0.20 | |
| Net Debt / Equity Ratio | -0.80 | -0.85 | -0.82 | -0.81 | -0.85 | -0.66 | |
| Net Debt / EBITDA Ratio | 0.77 | 1.31 | 1.10 | 3.38 | 4.37 | 2.40 | |
| Net Debt / FCF Ratio | 0.87 | 1.70 | 1.41 | 3.85 | 4.00 | 1.72 | |
| Asset Turnover | - | - | - | 0.08 | 0.04 | 0.15 | |
| Quick Ratio | 5.45 | 9.09 | 8.28 | 13.10 | 17.02 | 4.33 | |
| Current Ratio | 5.62 | 9.29 | 8.41 | 13.25 | 17.31 | 4.46 | |
| Return on Equity (ROE) | -71.73% | -65.65% | -61.69% | -23.44% | -30.03% | -44.34% | |
| Return on Assets (ROA) | -39.13% | -37.31% | -30.80% | -13.54% | -15.28% | -16.83% | |
| Return on Capital Employed (ROCE) | -99.50% | -63.50% | -70.50% | -23.30% | -18.70% | -24.10% | |
| Earnings Yield | -158.28% | -134.02% | -174.87% | -18.22% | -9.06% | -13.32% | |
| FCF Yield | -138.12% | -106.98% | -120.35% | -16.07% | -9.36% | -15.45% | |
| Buyback Yield / Dilution | -20.10% | -104.14% | -4.78% | -32.72% | -322.85% | -242.22% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.